Walleye Trading LLC Eagle Pharmaceuticals, Inc. Transaction History

Walleye Trading LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$34.37 - $60.07 $12,373 - $21,625	-360 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$54.32 - $64.31 $160,352 - $189,843	-2,952 Reduced 89.13%	360 $22,000
Q3 2019 Nov 14, 2019	SELL	$53.25 - $59.98 $159,590 - $179,760	-2,997 Reduced 47.5%	3,312 $187,000
Q2 2019 Aug 14, 2019	SELL	$46.61 - $58.45 $10,440 - $13,092	-224 Reduced 3.43%	6,309 $351,000
Q1 2019 May 15, 2019	BUY	$38.66 - $51.82 $217,617 - $291,694	5,629 Added 622.68%	6,533 $330,000
Q4 2018 Feb 14, 2019	SELL	$36.72 - $67.73 $196,268 - $362,016	-5,345 Reduced 85.53%	904 $36,000
Q3 2018 Nov 14, 2018	BUY	$66.65 - $83.86 $235,541 - $296,361	3,534 Added 130.17%	6,249 $433,000
Q2 2018 Aug 14, 2018	BUY	$51.25 - $76.62 $139,143 - $208,023	2,715 New	2,715 $205,000

8.59M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $9.5M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.